These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 342293)

  • 41. Prolonged remission of tumor-stage mycosis fungoides by topical immunotherpay.
    Vonderheid EC; Dellatorre DL; Van Scott EJ
    Arch Dermatol; 1981 Sep; 117(9):586-9. PubMed ID: 6457569
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Full clinical recovery after topical acyclovir treatment of Epstein-Barr virus associated cutaneous B-cell lymphoma in patient with mycosis fungoides.
    Copur MS; Deshpande A; Mleczko K; Norvell M; Hrnicek GJ; Woodward S; Frankforter S; Mandolfo N; Fu K; Chan WC
    Croat Med J; 2005 Jun; 46(3):458-62. PubMed ID: 15861527
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Topical mechlorethamine therapy for mycosis fungoides. Proposed schedule to overcome drug resistance.
    Volden G; Molin L; Thomsen K
    Arch Dermatol; 1982 Feb; 118(2):138-9. PubMed ID: 7059219
    [No Abstract]   [Full Text] [Related]  

  • 44. [Treatment of mycosis fungoides by PUVAtherapy. Report on 18 cases (author's transl)].
    Grupper CH; Berretti B; Schnitzler L; Bensoussan D
    Ann Dermatol Venereol; 1978 Mar; 105(3):291-8. PubMed ID: 677695
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Small malignant melanoma in patients with mycosis fungoides.
    Amichai B; Grunwald MH; Goldstein J; Finkelstein E; Halevy S
    J Eur Acad Dermatol Venereol; 1998 Sep; 11(2):155-7. PubMed ID: 9784043
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Topical 5-aminolevulinic acid photodynamic therapy for the treatment of unilesional mycosis fungoides: a report of two cases and review of the literature.
    Recio ED; Zambrano B; Alonso ML; de Eusebio E; Martín M; Cuevas J; Jaén P
    Int J Dermatol; 2008 Apr; 47(4):410-3. PubMed ID: 18377612
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Photochemotherapy for mycosis fungoides: a clinical and histological study.
    Lowe NJ; Cripps DJ; Dufton PA; Vickers CF
    Arch Dermatol; 1979 Jan; 115(1):50-3. PubMed ID: 760657
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Topical mechlorethamine. Cutaneous changes in patients with mycosis fungoides after its administration.
    Price NM
    Arch Dermatol; 1977 Oct; 113(10):1387-9. PubMed ID: 911166
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Topical chemotherapy and immunotherapy of mycosis fungoides: intermediate-term results.
    Vonderheid EC; Van Scott EJ; Johnson WC; Grekin DA; Asbell SO
    Arch Dermatol; 1977 Apr; 113(4):454-62. PubMed ID: 848974
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Scandinavian mycosis fungoides trial.
    Thomsen K
    Cancer Treat Rep; 1979 Apr; 63(4):709-11. PubMed ID: 445520
    [No Abstract]   [Full Text] [Related]  

  • 51. Mycosis fungoides presenting as pigmented purpuric dermatitis.
    Hanna S; Walsh N; D'Intino Y; Langley RG
    Pediatr Dermatol; 2006; 23(4):350-4. PubMed ID: 16918631
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Total cutaneous electron beam therapy of mycosis fungoides].
    Le Bourgeois JP; Levy E; Haddad E; Marinello G; Geara F; Pavlovitch JM
    Ann Dermatol Venereol; 1989; 116(3):213-7. PubMed ID: 2662874
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Combination chemotherapy with bleomycin, cyclophosphamide, prednisone and etretinate (BCPE) in advanced mycosis fungoides: a six-year experience.
    Zachariae H; Thestrup-Pedersen K
    Acta Derm Venereol; 1987; 67(5):433-7. PubMed ID: 2448996
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical stage IA (limited patch and plaque) mycosis fungoides. A long-term outcome analysis.
    Kim YH; Jensen RA; Watanabe GL; Varghese A; Hoppe RT
    Arch Dermatol; 1996 Nov; 132(11):1309-13. PubMed ID: 8915308
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Mycosis fungoides].
    Volden G; Eeg Larsen T
    Tidsskr Nor Laegeforen; 1977 Nov; 97(32):1671-5. PubMed ID: 594965
    [No Abstract]   [Full Text] [Related]  

  • 56. Second cutaneous malignancies in patients with mycosis fungoides treated with topical nitrogen mustard.
    Lee LA; Fritz KA; Golitz L; Fritz TJ; Weston WL
    J Am Acad Dermatol; 1982 Nov; 7(5):590-8. PubMed ID: 7142467
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Photochemotherapy and topical nitrogen mustard in the treatment of mycosis fungoides.
    du Vivier A; Vollum DI
    Br J Dermatol; 1980 Mar; 102(3):319-22. PubMed ID: 7370179
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Atypical cutaneous changes after topical treatment with nitrogen mustard in patients with mycosis fungoides.
    Reddy VB; Ramsay D; Garcia JA; Kamino H
    Am J Dermatopathol; 1996 Feb; 18(1):19-23. PubMed ID: 8721586
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Contact urticaria and anaphylactic reactions induced by topical application of nitrogen mustard].
    Sánchez Yus E; Surárez Martín E
    Actas Dermosifiliogr; 1977; 68(12):39-44. PubMed ID: 140594
    [No Abstract]   [Full Text] [Related]  

  • 60. Secondary cancers, comorbidities and mortality associated with nitrogen mustard therapy in patients with mycosis fungoides: a 30-year population-based cohort study.
    Lindahl LM; Fenger-Grøn M; Iversen L
    Br J Dermatol; 2014 Mar; 170(3):699-704. PubMed ID: 24024659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.